Complete transglutaminase 2 ablation results in reduced stroke volumes and astrocytes that exhibit increased survival in response to ischemia.
about
Transglutaminase is a therapeutic target for oxidative stress, excitotoxicity and stroke: a new epigenetic kid on the CNS blockTransglutaminase 2 has opposing roles in the regulation of cellular functions as well as cell growth and deathTissue transglutaminase in marmoset experimental multiple sclerosis: discrepancy between white and grey matter.Regulation of allergic lung inflammation by endothelial cell transglutaminase 2.Indomethacin induced gene regulation in the rat hippocampusTransglutaminase inhibition protects against oxidative stress-induced neuronal death downstream of pathological ERK activation.Method parameters' impact on mortality and variability in mouse stroke experiments: a meta-analysis.Endostatin and transglutaminase 2 are involved in fibrosis of the aging kidney.New aspects of gene-silencing for the treatment of cardiovascular diseasesTherapeutic implications of small interfering RNA in cardiovascular diseases.Transglutaminase 2 and neuroinflammation.Transglutaminase 2 modulation of NF-κB signaling in astrocytes is independent of its ability to mediate astrocytic viability in ischemic injury.The complex role of transglutaminase 2 in glioblastoma proliferation.Pituitary adenylate cyclase-activating polypeptide type 1 receptor (PAC1) gene is suppressed by transglutaminase 2 activation.Transglutaminase 2 facilitates or ameliorates HIF signaling and ischemic cell death depending on its conformation and localization.Depletion of transglutaminase 2 in neurons alters expression of extracellular matrix and signal transduction genes and compromises cell viability.Subcellular localization patterns of transglutaminase 2 in astrocytes and neurons are differentially altered by hypoxia.Inhibition or ablation of transglutaminase 2 impairs astrocyte migration.Cystamine improves functional recovery via axon remodeling and neuroprotection after stroke in mice.Transglutaminase 2: Friend or foe? The discordant role in neurons and astrocytes.Regulation of monocyte/macrophage polarisation by extracellular RNA
P2860
Q26824549-1641CAA4-2531-4616-AFD2-3E3604486B6EQ28069852-D08F5CCB-904D-4DD6-AA02-DC0609603820Q35193921-2371FF61-C498-4D13-9B62-45682606BF17Q36066483-B01F897C-F4B5-4608-B7FA-F6A5ECF06F4DQ36126839-1551384E-D135-4F69-9532-CC1DADD60DEEQ36241237-686A67F5-A076-401F-A14C-29E806720395Q36579398-22CD8AED-EACC-4415-91FA-B1A5EFE244CAQ36905578-8B700953-E98B-48AD-9C12-E3B6A6E82CA6Q37277425-3E60F018-82EB-42B6-8001-997F64D88F9FQ38023881-154393B3-4911-408D-B1CD-E4C2545C5824Q38268274-E9D0D9BB-05CF-467F-97FF-93D25C20FD0FQ38682039-50A86011-E86C-4211-8958-9AB5BDEC6094Q38824727-803DD15F-5497-4A19-9217-6A4FAAAA6DA1Q39094479-675D7CB3-ADB3-419D-9A59-0FB0DC0A25F2Q42403952-DE522573-BDBF-469D-8BE5-C01AC43A030DQ47338630-EC706484-C48A-437F-994B-5A7CCBB546C6Q47730518-DC3DCBA5-CFD8-4635-98A7-5EFEA3ECFDA3Q48412795-3DD8706A-0C67-485D-9755-A6DB0D0EE92CQ48445336-6A763BC8-7F09-4C4E-8A74-0779BA9CD234Q51736001-7EF841BC-3F99-4E49-8BD7-9385330FEE4DQ54592125-90656E3A-4B74-4B08-BC0D-3EBD5BB6EE0C
P2860
Complete transglutaminase 2 ablation results in reduced stroke volumes and astrocytes that exhibit increased survival in response to ischemia.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Complete transglutaminase 2 ab ...... vival in response to ischemia.
@en
type
label
Complete transglutaminase 2 ab ...... vival in response to ischemia.
@en
prefLabel
Complete transglutaminase 2 ab ...... vival in response to ischemia.
@en
P2860
P1476
Complete transglutaminase 2 ab ...... vival in response to ischemia.
@en
P2093
Gail V W Johnson
Gozde Colak
P2860
P304
P356
10.1016/J.NBD.2011.12.023
P577
2011-12-14T00:00:00Z